XML 45 R34.htm IDEA: XBRL DOCUMENT
v3.25.3

Industry Segments (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Schedule of Segment Information | The following table summarizes certain information regarding segments of the Company's continuing operations:
|  | Three Months Ended September 30, 2025 |  | Nine Months Ended September 30, 2025
(in thousands) |  | Specialty Chemicals |  | Corporate & Other 1 |  | Total Continuing Operations |  | Specialty Chemicals |  | Corporate & Other 1 |  | Total Continuing Operations
Net sales |  | $ | 19,697 |  |  | $ | — |  |  | $ | 19,697 |  |  | $ | 56,183 |  |  | $ | — |  |  | $ | 56,183 |
Cost of goods sold - material |  | 8,173 |  |  | — |  |  | 8,173 |  |  | 25,351 |  |  | — |  |  | 25,351 |
Cost of goods sold - other 2 |  | 5,683 |  |  | — |  |  | 5,683 |  |  | 17,059 |  |  | — |  |  | 17,059 |
Gross profit |  | 5,841 |  |  | — |  |  | 5,841 |  |  | 13,773 |  |  | — |  |  | 13,773 |
Selling, general and administrative expense 3 |  | 3,696 |  |  | 2,557 |  |  | 6,253 |  |  | 9,267 |  |  | 8,300 |  |  | 17,567 |
Acquisition costs and other |  | — |  |  | 398 |  |  | 398 |  |  | 92 |  |  | 573 |  |  | 665 |
Asset impairments |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,622 |  |  | 1,622 |
Gain on lease modification |  | — |  |  | — |  |  | — |  |  | — |  |  | (544) |  |  | (544) |
Interest expense (income), net |  | 7 |  |  | (454) |  |  | (447) |  |  | 38 |  |  | (385) |  |  | (347) |
Income taxes |  | — |  |  | 58 |  |  | 58 |  |  | — |  |  | (32) |  |  | (32) |
Other expense (income) |  | — |  |  | (296) |  |  | (296) |  |  | — |  |  | (581) |  |  | (581) |
Net income (loss) |  | $ | 2,138 |  |  | $ | (2,263) |  |  | $ | (125) |  |  | $ | 4,376 |  |  | $ | (8,953) |  |  | $ | (4,577) |
|  | Three Months Ended September 30, 2024 |  | Nine Months Ended September 30, 2024
(in thousands) |  | Specialty Chemicals |  | Corporate & Other 1 |  | Total Continuing Operations |  | Specialty Chemicals |  | Corporate & Other 1 |  | Total Continuing Operations
Net sales |  | $ | 20,878 |  |  | $ | — |  |  | $ | 20,878 |  |  | $ | 62,642 |  |  | $ | — |  |  | $ | 62,642 |
Cost of goods sold - material |  | 10,657 |  |  | — |  |  | 10,657 |  |  | 32,387 |  |  | — |  |  | 32,387 |
Cost of goods sold - other 2 |  | 7,088 |  |  | 125 |  |  | 7,213 |  |  | 22,653 |  |  | 395 |  |  | 23,048 |
Gross profit |  | 3,133 |  |  | (125) |  |  | 3,008 |  |  | 7,602 |  |  | (395) |  |  | 7,207 |
Selling, general and administrative expense 3 |  | 2,747 |  |  | 2,287 |  |  | 5,034 |  |  | 8,226 |  |  | 7,292 |  |  | 15,518 |
Acquisition costs and other |  | — |  |  | 2 |  |  | 2 |  |  | — |  |  | 54 |  |  | 54 |
Gain on lease modification |  | — |  |  | (67) |  |  | (67) |  |  | — |  |  | (67) |  |  | (67) |
Interest expense, net |  | 19 |  |  | 105 |  |  | 124 |  |  | 57 |  |  | 266 |  |  | 323 |
Income taxes |  | — |  |  | 5,807 |  |  | 5,807 |  |  | — |  |  | 4,413 |  |  | 4,413 |
Other expense (income) |  | — |  |  | (91) |  |  | (91) |  |  | — |  |  | (303) |  |  | (303) |
Net income (loss) |  | $ | 367 |  |  | $ | (8,168) |  |  | $ | (7,801) |  |  | $ | (681) |  |  | $ | (12,050) |  |  | $ | (12,731) |
| As of
(in thousands) | September 30, 2025 |  | December 31, 2024
Identifiable assets |  |  |
Specialty Chemicals | $ | 39,130 |  |  | $ | 38,928 |
Corporate and other | 80,759 |  |  | 46,298 |
| $ | 119,889 |  |  | $ | 85,226 |
1 All Other includes corporate overhead expenses and ongoing expenses for properties under the Master Lease not assigned to a segment in which the Company is the responsible party. 2 Cost of good sold - other includes manufacturing labor and overhead expenses, depreciation expense, repair and maintenance expense, shipping expense, scrap and shrinkage expense, and other operational manufacturing overhead expenses. 3 Selling, general and administrative expenses include sales and administrative salaries, wages and benefits and overhead expenses, professional fees, depreciation and amortization expense, corporate overhead allocation expense and other administrative overhead expenses.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration